StonvexLoading…
StonvexStonvexStonvexCore line items from HCM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $548.51M | $630.20M | $838.00M | $426.41M |
Operating Income | $-39.16M | $-43.70M | $18.38M | $-407.69M |
Net Income | $456.91M | $37.73M | $100.78M | $-360.83M |
EPS (Diluted) | $0.52 | $0.04 | $0.12 | $-0.43 |
Total Assets | $1.75B | $1.27B | $1.28B | $1.03B |
Total Liabilities | $501.83M | $502.34M | $536.39M | $392.57M |
Cash & Equivalents | $71.33M | $153.96M | $283.59M | $313.28M |
Free Cash Flow OCF − CapEx | $-78.81M | $-17.44M | $186.65M | $-305.26M |
Shares Outstanding | 872.89M | 872.83M | 869.20M | 847.14M |